Designed for founders, operators, and finance leaders, this session will provide perspectives from a panel of experts in identifying and securing non-dilutive funding to drive business growth. Attendees will learn how to effectively and efficiently secure grants, tax credits, and other non-dilutive funding options as part of their holistic financing strategy. The panel will feature:
Andrew MacIsaac, CEO of Applied Pharmaceutical Innovation (API). Andrew has extensive experience in the life sciences sector, having built partnerships across industry, government, and academia to secure transformative infrastructure and catalyze the development of life sciences products and companies.
Dr. Katie Greene, Director of Operations at Thin Air Labs. Katie is an award-winning biochemist turned venture builder, helping ventures across Canada secure $65m+ in funding to support their growth.
This event is brought to you by Applied Pharmaceutical Innovations and Thin Air Labs’ Funding Catalyst team, which has helped companies secure $65m+ in funding since 2022. Attendees can participate in person at Edmonton Unlimited or virtually via Zoom.